HDAC6 Cancer Research Results
HDAC6, HDAC6: Click to Expand ⟱
| Source: |
| Type: |
Histone deacetylase 6 (HDAC6) is a cytoplasmic enzyme that plays a significant role in regulating various cellular processes, and its dysregulation has been implicated in cancer pathogenesis and progression.
-HDAC6 primarily deacetylates non-histone proteins, including α-tubulin and heat shock protein 90 (Hsp90).
-Many studies have reported overexpression or hyperactivation of HDAC6 in different cancer types.
|
Scientific Papers found: Click to Expand⟱
antiOx↑, Inflam↓, Bacteria↓, chemoPv↑, TumCCA↑, Apoptosis↑, ChemoSen↑, TumCP↓, TumCI↓, TumMeta↓, DNMTs↓, HDAC↓, HDAC6↓, AR↓, selectivity↑, CDK1↓, CycB/CCNB1↓, P53↑, WEE1↑, CDC25↓, cMyc↓, cycD1/CCND1↓, cycE/CCNE↓, CDK4↓, CDK6↓, XIAP↓, survivin↓, Bcl-2↓, compIII↓, APAF1↑, ROS↑, OXPHOS↓, MMP↓, Ca+2↑, CXCR4↓, IL6↓, JAK2↓, STAT3↓, mTOR↓, Synergy↑, CSCs↓, uPAR↓, NF-kB↓, TGF-β↓, angioG↓,
tumCV↓, TumCP↓, Apoptosis↑, Casp↑, TumCCA↑, Inflam↓, NF-kB↓, CCN2/CTGF↓, IL6↓, COX2/PTGS2↓, iNOS↓, toxicity↓, *ROS↓, ROS↑, *SOD↑, *Catalase↑, PI3K↓, Akt↓, mTOR↓, DNMT1↓, DNMT3A↓, DNMT3B↓, HDAC6↓,
TumCMig↓, TumCI↓, MMP9↓, α-tubulin↑, HDAC6↓, HSP90↓,
MMP9↓, α-tubulin↑, TumCI↓, HDAC6↓, HSP90↓, TumCMig↓, EGFR↓,
DNMTs↓, HDAC↓, HMTs↓, DNMT3A↓, EZH2↓, HDAC1↓, HDAC2↓, HDAC6↓, HDAC11↓, G9a↓, TIMP3↑, PTEN↑, SOCS1↑,
chemoPv↑, antiNeop↑, Risk↓, Ingr↝, NRF2↑, NQO1↑, ROS↑, MMP↓, Cyt‑c↑, Apoptosis↑, STAT3↓, Bcl-2↓, cycD1/CCND1↓, survivin↓, HDAC↓, DNMTs↓, HDAC3↓, HDAC6↓, Akt↓, TumCG↓, BioAv↑, Half-Life↝, PSA↓, PSADT↑,
Showing Research Papers: 1 to 6 of 6
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 6
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, NQO1↑, 1, NRF2↑, 1, ROS↑, 3,
Mitochondria & Bioenergetics(tgid=3) ⓘ
CDC25↓, 1, compIII↓, 1, OXPHOS↓, 1,
Cell Death(tgid=5) ⓘ
APAF1↑, 1, Apoptosis↑, 3, Bcl-2↓, 2, Casp↑, 1, Cyt‑c↑, 1, iNOS↓, 1, survivin↓, 2, XIAP↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 2, EGFR↓, 1, JAK2↓, 1, mTOR↓, 2, PI3K↓, 1, PTEN↑, 1, STAT3↓, 2,
Transcription & Epigenetics(tgid=7) ⓘ
cMyc↓, 1, DNMT1↓, 1, DNMT3A↓, 2, DNMT3B↓, 1, DNMTs↓, 3, EZH2↓, 1, HDAC↓, 3, HDAC1↓, 1, HDAC11↓, 1, HDAC2↓, 1, HDAC3↓, 1, HDAC6↓, 6, HMTs↓, 1, tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP90↓, 2,
DNA Damage & Repair(tgid=10) ⓘ
G9a↓, 1, P53↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, CDK4↓, 1, CDK6↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 2, cycE/CCNE↓, 1, TumCCA↑, 2, WEE1↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, TumCG↓, 1, TumCP↓, 2,
Migration(tgid=13) ⓘ
Ca+2↑, 1, CCN2/CTGF↓, 1, MMP9↓, 2, TGF-β↓, 1, TIMP3↑, 1, TumCI↓, 3, TumCMig↓, 2, TumMeta↓, 1, uPAR↓, 1, α-tubulin↑, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1,
Barriers & Transport(tgid=15) ⓘ
MMP↓, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, CXCR4↓, 1, IL6↓, 2, Inflam↓, 2, NF-kB↓, 2, PSA↓, 1, SOCS1↑, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
AR↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, ChemoSen↑, 1, Half-Life↝, 1, selectivity↑, 1, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
AR↓, 1, EGFR↓, 1, EZH2↓, 1, IL6↓, 2, PSA↓, 1, PSADT↑, 1,
Functional Outcomes(tgid=23) ⓘ
antiNeop↑, 1, chemoPv↑, 2, Risk↓, 1, toxicity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Ingredients & Constituents(tgid=25) ⓘ
Ingr↝, 1,
Total Targets: 87
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↑, 1, ROS↓, 1, SOD↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: HDAC6, HDAC6
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1335 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page